GSA Capital Partners LLP Has $928,000 Stock Position in Arteris, Inc. (NASDAQ:AIP)

GSA Capital Partners LLP cut its stake in shares of Arteris, Inc. (NASDAQ:AIPFree Report) by 9.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 120,240 shares of the company’s stock after selling 12,801 shares during the period. GSA Capital Partners LLP owned approximately 0.31% of Arteris worth $928,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Essex Investment Management Co. LLC acquired a new position in shares of Arteris during the 3rd quarter worth about $2,504,000. Silvercrest Asset Management Group LLC grew its holdings in Arteris by 25.2% during the first quarter. Silvercrest Asset Management Group LLC now owns 711,903 shares of the company’s stock valued at $5,211,000 after purchasing an additional 143,385 shares during the period. Acadian Asset Management LLC increased its stake in Arteris by 28.1% in the first quarter. Acadian Asset Management LLC now owns 534,472 shares of the company’s stock valued at $3,911,000 after purchasing an additional 117,312 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Arteris in the second quarter worth $580,000. Finally, CloudAlpha Capital Management Limited Hong Kong bought a new position in shares of Arteris during the second quarter worth $554,000. Institutional investors own 64.36% of the company’s stock.

Arteris Stock Down 1.8 %

Shares of AIP stock opened at $7.80 on Friday. Arteris, Inc. has a 12-month low of $4.33 and a 12-month high of $9.54. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The firm has a fifty day moving average of $7.37 and a 200-day moving average of $7.71. The company has a market capitalization of $313.38 million, a price-to-earnings ratio of -8.13 and a beta of 1.13.

Insider Buying and Selling

In related news, VP Paul L. Alpern sold 3,615 shares of the stock in a transaction dated Friday, October 4th. The stock was sold at an average price of $7.13, for a total transaction of $25,774.95. Following the completion of the transaction, the vice president now directly owns 68,084 shares in the company, valued at approximately $485,438.92. This trade represents a 5.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Wayne C. Cantwell sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $6.95, for a total value of $104,250.00. Following the completion of the sale, the director now owns 243,198 shares in the company, valued at $1,690,226.10. The trade was a 5.81 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 143,409 shares of company stock valued at $1,059,138. Company insiders own 33.70% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on AIP shares. Westpark Capital reaffirmed a “buy” rating and set a $11.00 price objective on shares of Arteris in a research note on Wednesday, July 31st. Rosenblatt Securities restated a “buy” rating and issued a $15.00 price target on shares of Arteris in a report on Wednesday, November 6th.

View Our Latest Analysis on AIP

Arteris Profile

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.